| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
RET, ROS1 and ALK fusions in lung cancer.
|
Nat Med
|
2012
|
6.76
|
|
2
|
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details.
|
Mod Rheumatol
|
2011
|
4.26
|
|
3
|
Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study.
|
J Clin Oncol
|
2011
|
3.10
|
|
4
|
Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System.
|
Int J Hematol
|
2007
|
2.43
|
|
5
|
Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM.
|
Oncogene
|
2005
|
2.36
|
|
6
|
Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients.
|
Clin Cancer Res
|
2007
|
2.25
|
|
7
|
Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5.
|
Blood
|
2006
|
2.16
|
|
8
|
Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients.
|
Am J Surg Pathol
|
2003
|
2.06
|
|
9
|
Gain-of-function mutations and copy number increases of Notch2 in diffuse large B-cell lymphoma.
|
Cancer Sci
|
2009
|
1.95
|
|
10
|
Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.
|
Blood
|
2008
|
1.86
|
|
11
|
Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
|
Cancer Sci
|
2008
|
1.75
|
|
12
|
Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia.
|
Blood
|
2005
|
1.66
|
|
13
|
Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8/8 allele-matched unrelated transplantation: a nationwide retrospective study.
|
Blood
|
2011
|
1.65
|
|
14
|
Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study.
|
Blood
|
2012
|
1.63
|
|
15
|
Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL-positive acute lymphoblastic leukemia.
|
Blood
|
2014
|
1.55
|
|
16
|
De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.
|
Blood
|
2002
|
1.52
|
|
17
|
Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
|
Genes Chromosomes Cancer
|
2005
|
1.47
|
|
18
|
Comparison of intravenous with oral busulfan in allogeneic hematopoietic stem cell transplantation with myeloablative conditioning regimens for pediatric acute leukemia.
|
Biol Blood Marrow Transplant
|
2013
|
1.42
|
|
19
|
Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study.
|
Blood
|
2010
|
1.42
|
|
20
|
The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
|
Am J Hematol
|
2014
|
1.40
|
|
21
|
Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease.
|
Rev Med Virol
|
2008
|
1.34
|
|
22
|
Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.
|
J Clin Oncol
|
2013
|
1.14
|
|
23
|
Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study.
|
Biol Blood Marrow Transplant
|
2008
|
1.13
|
|
24
|
Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review.
|
J Clin Exp Hematop
|
2006
|
1.13
|
|
25
|
Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia.
|
Biol Blood Marrow Transplant
|
2011
|
1.10
|
|
26
|
Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
|
J Clin Oncol
|
2006
|
1.08
|
|
27
|
Aggressive natural killer cell leukemia: therapeutic potential of L-asparaginase and allogeneic hematopoietic stem cell transplantation.
|
Cancer Sci
|
2012
|
1.07
|
|
28
|
Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.
|
Clin Cancer Res
|
2012
|
1.06
|
|
29
|
De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.
|
Haematologica
|
2008
|
1.02
|
|
30
|
Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases.
|
Cancer Res
|
2004
|
1.02
|
|
31
|
NK-cell neoplasms in Japan.
|
Hematology
|
2005
|
1.00
|
|
32
|
Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study.
|
Blood
|
2012
|
1.00
|
|
33
|
Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes.
|
Blood
|
2009
|
0.98
|
|
34
|
Molecular cytogenetic analysis of the breakpoint region at 6q21-22 in T-cell lymphoma/leukemia cell lines.
|
Genes Chromosomes Cancer
|
2002
|
0.97
|
|
35
|
Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified.
|
Am J Surg Pathol
|
2005
|
0.97
|
|
36
|
Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma.
|
Am J Hematol
|
2004
|
0.96
|
|
37
|
Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms.
|
Br J Haematol
|
2005
|
0.95
|
|
38
|
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group.
|
J Hematol Oncol
|
2013
|
0.95
|
|
39
|
Nucleophosmin in acute myelogenous leukemia.
|
N Engl J Med
|
2005
|
0.93
|
|
40
|
MALT1 contains nuclear export signals and regulates cytoplasmic localization of BCL10.
|
Blood
|
2005
|
0.93
|
|
41
|
Haematopoietic stem cell transplantation for relapsed or refractory anaplastic large cell lymphoma: a study of children and adolescents in Japan.
|
Br J Haematol
|
2014
|
0.93
|
|
42
|
Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
|
Histopathology
|
2011
|
0.92
|
|
43
|
Clinical factors predicting the response of acute graft-versus-host disease to corticosteroid therapy: an analysis from the GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation.
|
Biol Blood Marrow Transplant
|
2013
|
0.91
|
|
44
|
Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization.
|
Genes Chromosomes Cancer
|
2004
|
0.90
|
|
45
|
Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell Transplantation.
|
Biol Blood Marrow Transplant
|
2012
|
0.90
|
|
46
|
Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry.
|
Int J Hematol
|
2010
|
0.89
|
|
47
|
Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia: a report from the BINGO study.
|
Cancer Sci
|
2010
|
0.88
|
|
48
|
Contig array CGH at 3p14.2 points to the FRA3B/FHIT common fragile region as the target gene in diffuse large B-cell lymphoma.
|
Oncogene
|
2004
|
0.87
|
|
49
|
Pilot phase I/II study of new salvage therapy (CHASE) for refractory or relapsed malignant lymphoma.
|
Int J Hematol
|
2003
|
0.87
|
|
50
|
Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
|
Biol Blood Marrow Transplant
|
2007
|
0.86
|
|
51
|
Centroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 cases.
|
Mod Pathol
|
2002
|
0.85
|
|
52
|
Concurrent chemoradiotherapy for limited-stage extranodal natural killer/t-cell lymphoma, nasal type.
|
J Clin Oncol
|
2010
|
0.85
|
|
53
|
Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission.
|
Blood
|
2010
|
0.85
|
|
54
|
Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study.
|
Biol Blood Marrow Transplant
|
2013
|
0.84
|
|
55
|
MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
|
Jpn J Cancer Res
|
2002
|
0.84
|
|
56
|
MASL1, a candidate oncogene found in amplification at 8p23.1, is translocated in immunoblastic B-cell lymphoma cell line OCI-LY8.
|
Oncogene
|
2004
|
0.84
|
|
57
|
Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin.
|
Int J Hematol
|
2012
|
0.84
|
|
58
|
Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia.
|
Int J Hematol
|
2011
|
0.84
|
|
59
|
Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18) (q21;q21) MALT lymphoma.
|
Oncogene
|
2003
|
0.83
|
|
60
|
Impact of hepatitis C virus infection on clinical outcome in recipients after allogeneic hematopoietic cell transplantation.
|
Am J Hematol
|
2013
|
0.83
|
|
61
|
More on crizotinib.
|
N Engl J Med
|
2011
|
0.83
|
|
62
|
High-grade mature B-cell lymphoma with Burkitt-like morphology: results of a clinicopathological study of 72 Japanese patients.
|
Cancer Sci
|
2008
|
0.83
|
|
63
|
Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma.
|
Leuk Lymphoma
|
2007
|
0.82
|
|
64
|
Guidelines for the management of cutaneous lymphomas (2011): a consensus statement by the Japanese Skin Cancer Society - Lymphoma Study Group.
|
J Dermatol
|
2012
|
0.82
|
|
65
|
Reduced-intensity versus conventional myeloablative conditioning for patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in complete remission.
|
Blood
|
2011
|
0.82
|
|
66
|
The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma.
|
Hematol Oncol
|
2010
|
0.81
|
|
67
|
Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
|
Am J Hematol
|
2007
|
0.80
|
|
68
|
Comparison of genetic aberrations in CD10+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization.
|
Cancer Sci
|
2004
|
0.80
|
|
69
|
Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era.
|
Cancer Sci
|
2015
|
0.80
|
|
70
|
[Hematopoietic cell transplantation in Japan: nationwide survey 2013].
|
Rinsho Ketsueki
|
2014
|
0.79
|
|
71
|
Phenotypic analysis of peripheral T/NK cell lymphoma: study of 408 Japanese cases with special reference to their anatomical sites.
|
Pathol Int
|
2003
|
0.79
|
|
72
|
Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan.
|
Int J Hematol
|
2008
|
0.78
|
|
73
|
Lack of association between DNA base excision repair gene XRCC1 Gln399Arg polymorphism and risk of malignant lymphoma in Japan.
|
Cancer Genet Cytogenet
|
2004
|
0.78
|
|
74
|
Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma.
|
Int J Hematol
|
2010
|
0.78
|
|
75
|
Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor.
|
Int J Hematol
|
2010
|
0.78
|
|
76
|
Micafungin for empirical antifungal therapy in patients with febrile neutropenia: multicenter phase 2 study.
|
Int J Hematol
|
2013
|
0.78
|
|
77
|
Differences between nasal and extranasal NK/T-cell lymphoma.
|
Blood
|
2009
|
0.77
|
|
78
|
Feasibility of reduced-intensity conditioning followed by unrelated cord blood transplantation for primary hemophagocytic lymphohistiocytosis: a nationwide retrospective analysis in Japan.
|
Int J Hematol
|
2013
|
0.77
|
|
79
|
Dosing of a phase I study of KW-0761, an anti-CCR4 antibody, for adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
|
J Clin Oncol
|
2010
|
0.76
|
|
80
|
Phase II study of dose-modified busulfan by real-time targeting in allogeneic hematopoietic stem cell transplantation for myeloid malignancy.
|
Cancer Sci
|
2012
|
0.76
|
|
81
|
Hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia and Down syndrome.
|
Pediatr Blood Cancer
|
2014
|
0.76
|
|
82
|
Mycophenolate mofetil use after unrelated hematopoietic stem cell transplantation for prophylaxis and treatment of graft-vs.-host disease in adult patients in Japan.
|
Clin Transplant
|
2014
|
0.75
|
|
83
|
[Guideline for T/NK-cell lymphoma].
|
Rinsho Ketsueki
|
2013
|
0.75
|
|
84
|
Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy followed by autologous stem cell transplant.
|
Leuk Lymphoma
|
2010
|
0.75
|
|
85
|
Stem cell transplantation for paediatric patients with non-anaplastic peripheral T-cell lymphoma in Japan.
|
Br J Haematol
|
2012
|
0.75
|
|
86
|
[Extranodal NK/T-cell lymphoma].
|
Nihon Rinsho
|
2014
|
0.75
|
|
87
|
Efficacy and long-term outcome of treatment for pure red cell aplasia after allogeneic stem cell transplantation from major ABO-incompatible donors.
|
Biol Blood Marrow Transplant
|
2013
|
0.75
|
|
88
|
Huge mass of cutaneous-type adult T-cell leukemia which responded to interferon gamma.
|
Intern Med
|
2007
|
0.75
|
|
89
|
Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematological malignancies.
|
Int J Infect Dis
|
2013
|
0.75
|
|
90
|
[The unification of hematopoietic stem cell transplantation registry in Japan and establishment of the TRUMP system].
|
Rinsho Ketsueki
|
2007
|
0.75
|
|
91
|
[Successful salvage therapy with cladribine and rituximab for a patient with a relapsed Asian variant of intravascular large B-cell lymphoma].
|
Rinsho Ketsueki
|
2006
|
0.75
|
|
92
|
Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan.
|
Int J Hematol
|
2011
|
0.75
|
|
93
|
[Future perspectives of research and clinical studies for NK-cell malignancy in Asia].
|
Rinsho Ketsueki
|
2008
|
0.75
|
|
94
|
Pseudo-Gaucher cells in light chain plasma cell myeloma.
|
Am J Hematol
|
2006
|
0.75
|
|
95
|
Overview.
|
Rinsho Ketsueki
|
2016
|
0.75
|
|
96
|
Mylotarg is not a "magic bullet".
|
Int J Hematol
|
2006
|
0.75
|
|
97
|
Prognostic significance of NPM-ALK fusion transcript overexpression in ALK-positive anaplastic large-cell lymphoma.
|
Mod Pathol
|
2007
|
0.75
|
|
98
|
[Molecular target therapy for malignant lymphoma].
|
Rinsho Ketsueki
|
2008
|
0.75
|